Table 5.
Correlation of overall tumor biomarker response with objective tumor response.a
| Overall tumor biomarker response | RECIST responsea, n (%) | Correlation coefficient (P-value) | |||
|---|---|---|---|---|---|
| PR | SD | PD | Fisher’s exact P-value | ||
| All baseline ≥ 1.5x ULN (n - =55) |
Responder | 7 (13) | 6 (11) | 0 (0) | 0.36 (0.007) 0.012 |
| Non-responder | 7 (13) | 32 (58) | 3 (5) | ||
| NE-hypersecreting (n = 52) | Responder | 7 (13) | 6 (12) | 0 (0) | 0.38 (0.005) 0.010 |
| Non-responder | 6 (12) | 30 (58) | 3 (6) | ||
| NE-only-hypersecreting (n = 28) | Responder | 5 (18) | 5 (18) | 0 (0) | 0.35 (0.065) 0.091 |
| Non-responder | 3 (11) | 13 (46) | 2 (7) | ||
| EPI-only-hypersecreting (n = 3) | Responder | 0 (0) | 0 (0) | 0 (0) | N/A |
| Non-responder | 1 (33) | 2 (67) | 0 (0) | ||
aBest confirmed response of complete response or partial response according to Response Evaluation Criteria in Solid Tumors.
EPI, epinephrine; NE, norepinephrine; PD, progressive disease; PR, partial response; SD, stable disease; ULN, upper limit of normal.
This work is licensed under a